Wikidata

(Q42914716)

English

Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

scientific article published on 7 September 2010

In more languages

Statements

title
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20823406
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20823406%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
author

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42914716&oldid=1858029293"